| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 5, 2567-2574, Copyright © 1991 by The Federation of American Societies for Experimental Biology
REVIEWS |
R Fernandez-Botran
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas 75235.
A number of cytokine receptors exist in soluble form in the biological fluids of both animals and humans, a phenomenon that might have immunoregulatory implications in vivo. Although these soluble receptors specifically inhibit binding and activity of their respective cytokines in vitro, their actual function in vivo as cytokine inhibitors or as carrier proteins is unclear. Abnormalities in the production of these substances might contribute to the pathophysiology of immune and neoplastic diseases. Besides their role in regulating cytokine activity in vivo, soluble cytokine receptors hold significant potential for therapeutic use as very specific anticytokine agents and as indicators in diagnosis and assessment of immune parameters, prognosis, disease progression, response to treatment, etc., in a variety of autoimmune and malignant diseases.
This article has been cited by other articles:
|
|
 |
|
  N. A. de Weerd, S. A. Samarajiwa, and P. J. Hertzog Type I Interferon Receptors: Biochemistry and Biological Functions J. Biol. Chem., July 13, 2007; 282(28): 20053 - 20057. [Full Text] [PDF]
|
|
|
|
|
|
J. Coers, C. Ranft, and R. C. Skoda A Truncated Isoform of c-Mpl with an Essential C-terminal Peptide Targets the Full-length Receptor for Degradation J. Biol. Chem., August 27, 2004; 279(35): 36397 - 36404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Marano, L. A. Garulacan, K. V. Laughlin, L. Igidbashian, C. Trace, S. M. Goldman, F. P. Sutter, G. A. Reichard Jr, and J. M. Mullin Plasma concentrations of soluble tumor necrosis factor receptor I and tumor necrosis factor during cardiopulmonary bypass Ann. Thorac. Surg., October 1, 2000; 70(4): 1313 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Oaks and K. M. Hallett Cutting Edge: A Soluble Form of CTLA-4 in Patients with Autoimmune Thyroid Disease J. Immunol., May 15, 2000; 164(10): 5015 - 5018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Murase, N. Kume, H. Kataoka, M. Minami, T. Sawamura, T. Masaki, and T. Kita Identification of Soluble Forms of Lectin-Like Oxidized LDL Receptor-1 Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 715 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ayroldi, F. D'Adamio, O. Zollo, M. Agostini, R. Moraca, L. Cannarile, G. Migliorati, D. V. Delfino, and C. Riccardi Cloning and Expression of a Short Fas Ligand: A New Alternatively Spliced Product of the Mouse Fas Ligand Gene Blood, November 15, 1999; 94(10): 3456 - 3467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Shibata, H Goto, T Arisawa, Y Niwa, T Hayakawa, A Nakayama, and N Mori Regulation of tumour necrosis factor (TNF) induced apoptosis by soluble TNF receptors in Helicobacter pylori infection Gut, July 1, 1999; 45(1): 24 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Lodato, A. R. Khan, M. J. Zembowicz, N. W. Weisbrodt, T. A. Pressley, Y.-F. Li, J. A. Lodato, A. Zembowicz, and F. G. Moody Roles of IL-1 and TNF in the decreased ileal muscle contractility induced by lipopolysaccharide Am J Physiol Gastrointest Liver Physiol, June 1, 1999; 276(6): G1356 - G1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Yabkowitz, S. Meyer, T. Black, G. Elliott, L. A. Merewether, and H. K. Yamane Inflammatory Cytokines and Vascular Endothelial Growth Factor Stimulate the Release of Soluble Tie Receptor From Human Endothelial Cells Via Metalloprotease Activation Blood, March 15, 1999; 93(6): 1969 - 1979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hirashima, S. Nakamura, M. Suzuki, M. Kurimoto, S. Endo, A. Ogawa, and A. Takaku Cerebrospinal Fluid Tissue Factor and Thrombin-Antithrombin III Complex as Indicators of Tissue Injury After Subarachnoid Hemorrhage Stroke, September 1, 1997; 28(9): 1666 - 1670. [Abstract] [Full Text]
|
|
|
|
|
|
R. Yabkowitz, S. Meyer, D. Yanagihara, D. Brankow, T. Staley, G. Elliott, S. Hu, and B. Ratzkin Regulation of Tie Receptor Expression on Human Endothelial Cells by Protein Kinase C-Mediated Release of Soluble Tie Blood, July 15, 1997; 90(2): 706 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. V. Subramanian, M. L. Fitzgerald, and M. Bernfield Regulated Shedding of Syndecan-1 and -4 Ectodomains by Thrombin and Growth Factor Receptor Activation J. Biol. Chem., June 6, 1997; 272(23): 14713 - 14720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Deng, C. W. Rettenmier, and P. K. Pattengale Structural Requirements for the Ectodomain Cleavage of Human Cell Surface Macrophage Colony-stimulating Factor J. Biol. Chem., July 5, 1996; 271(27): 16338 - 16343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Arribas, L. Coodly, P. Vollmer, T. K. Kishimoto, S. Rose-John, and J. Massagué Diverse Cell Surface Protein Ectodomains Are Shed by a System Sensitive to Metalloprotease Inhibitors J. Biol. Chem., May 10, 1996; 271(19): 11376 - 11382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Cheng, T Zhou, C Liu, J. Shapiro, M. Brauer, M. Kiefer, P. Barr, and J. Mountz Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule Science, March 25, 1994; 263(5154): 1759 - 1762. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
